Evans Analytical Group


Evans Analytical Group® (EAG) is a testing organization that has delivered analytical services in materials characterization and surface analysis for over 30 years. More recently, they have expanded into the electronic testing area, via their Release to Production division, and into regulated pharmaceutical and medical device testing, via their Life Sciences division. Since their inception in 1978 as Charles Evans & Associates, their guiding principal has been innovative problem solving, underscored by a commitment to excellence (1a).

Facilities and Research Initiatives

EAG is capable of working with challenging materials, electronics and product development problems across multiple industries. They collaborate with their customers throughout the process/product development and production cycles to provide the best analytical and testing approaches and to provide the greatest value with the most efficient use of resources (1a).

EAG recently announced their newest addition in analytical application capabilities - Electron Backscatter Diffraction (EBSD).  The EBSD is a tool used to characterize the grain structure of crystalline materials. EBSD uses an SEM beam to scan a sample and collect diffraction patterns from every point in the SEM image, providing information such as grain size (histograms and averages), grain shape, grain orientation (texture), deformation, and phase distribution (1b).

Evans Analytical Group will be attending the BIOMEDevice San Jose Conference in December 2012.  The BIOMEDevice San Jose Conference provides a comprehensive guide to medical device product development.  The conference provides networking with representatives from over 2,000+ regional medtech OEMs and is hosted by Nelson Laboratories, Zeus, and MEMS Industry Group® (2). 

EAG is a leading analysis and testing organization, serving more than 3,000 companies across more than 50 countries. There are 18 locations throughout the North America, Europe, and Asia (1a).

Strategic Partnerships

Evans Analytical Group has used their analytical services to aid other companies with research and development.  Recently, BluGlass’ RPCVD grown GaN layers demonstrated reduced levels of impurities of carbon, hydrogen and oxygen. The company stated that the impurities are on par with the industry standard process, MOCVD, for its GaN layers.  The impurity levels were measured by Evans Analytical Group (EAG), an independent, global materials characterization company, using Secondary Ion Mass Spectrometry (SIMS).  EAG has confirmed that BluGlass has demonstrated carbon, oxygen and hydrogen impurities at levels less than 1x1017 atoms cm-3 (3).


  1. Evans Analytical Group  (2012). Retrieved on November 16, 2012.
    1. “About” from www.eaglabs.com/about-eag.html
    2. “EAG adds Electron Backscatter Diffraction (EBSD) services”  (2012, June 20) from www.eaglabs.com/06-20-12-ebsdpr.html
  2. UBM Canon (2012). “BIOMEDevice San Jose Conference.” Retrieved on November 16, 2012 from www.canontradeshows.com/expo/biomed12              
  3. Compound Semiconductor (2012, October 29). “BluGlass Drives Down Defects In GaN Films Grown By RPCVD.” Retrieved on November 16, 2012 from www.compoundsemiconductor.net/csc/news-details/id/19735669/name/BluGlass-drives-down-defects-in-GaN-films-grown-by-RPCV.html